Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is Jones, Robin L  [Clear All Filters]
C
Cheung, MC, Jones RL, Judson I.  2011.  Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case report.. Journal of medical case reports. 5:180.
Constantinidou, A, Pollack S, Loggers E, Rodler E, Jones RL.  2013.  The evolution of systemic therapy in sarcoma.. Expert review of anticancer therapy. 13(2):211-23. Abstract
Constantinidou, A, Jones RL, Olmos D, Thway K, Fisher C, Al-Muderis O, Judson I.  2012.  Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour.. Acta oncologica (Stockholm, Sweden). 51(4):550-554.
F
Ferreira, BP, Rodler ET, Loggers ET, Pollack SM, Jones RL.  2012.  Systemic therapy in primary angiosarcoma of the spleen.. Rare tumors. 4(4):e55. Abstract
J
Jones, RL, Constantinidou A, Olmos D, Thway K, Fisher C, Al-Muderis O, Scurr M, Judson IR.  2012.  Role of palliative chemotherapy in advanced epithelioid sarcoma.. American journal of clinical oncology. 35(4):351-7. Abstract
Jones, RL, Constantinidou A.  2012.  The efficacy of caffeine-potentiated chemotherapy in clear cell sarcoma.. International journal of clinical oncology / Japan Society of Clinical Oncology.
Jones, RL, Olmos D, Thway K, Fisher C, Tunariu N, Postel-Vinay S, Scurr M, de Bono J, Kaye SB, Judson IR.  2011.  Clinical benefit of early phase clinical trial participation for advanced sarcoma patients.. Cancer chemotherapy and pharmacology. 68(2):423-9. Abstract
M
Mazbani, E, Jones RL, Fink J, Chamberlain MC.  2013.  Delayed development of a rhabdomyosarcoma following radiation for a spinal cord glioma.. Journal of neuro-oncology. Abstract
N
Newman, EN, Jones RL, Hawkins DS.  2012.  An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing Sarcoma.. Pediatric blood & cancer. Abstract
O
Olmos, D, Martins AS, Jones RL, Alam S, Scurr M, Judson IR.  2011.  Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations.. Sarcoma. 2011:402508. Abstract
P
Pollack, SM, Loggers ET, Rodler ET, Yee C, Jones RL.  2011.  Immune-based therapies for sarcoma.. Sarcoma. 2011:438940. Abstract
Pollack, SM, Jungbluth AA, Hoch BL, Farrar EA, Bleakley M, Schneider DJ, Loggers ET, Rodler E, Eary JF, Conrad Iii EU et al..  2012.  NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.. Cancer. Abstract
Pollack, SM, Li Y, Blaisdell MJ, Farrar EA, Chou J, Hoch BL, Loggers ET, Rodler E, Eary JF, Conrad EU et al..  2012.  NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.. PloS one. 7(2):e32165. Abstract
R
Rajendra, R, Jones RL, Pollack SM.  2013.  Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib.. OncoTargets and therapy. 6:217-22. Abstract
Rajendra, R, Pollack SM, Jones RL.  2013.  Management of gastrointestinal stromal tumors.. Future oncology (London, England). 9(2):193-206. Abstract
S
Sanfilippo, R, Grosso F, Jones RL, Banerjee S, Pilotti S, D'Incalci M, Tos APD, Raspagliesi F, Judson I, Casali PG.  2011.  Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centers.. Gynecologic oncology. 123(3):553-6. Abstract
Schroeder, BA, Rodler ET, Loggers ET, Pollack SM, Jones RL.  2013.  Clinical benefit of trabectedin in uterine adenosarcoma.. Medical oncology (Northwood, London, England). 30(2):501. Abstract